Bristol Myers Squibb (BMY) reported strong Q4 earnings earlier in February, and prospects remain strong for 2025, although it may face some headwinds. The recent earnings announcement for the company…
Category:
Stocks
-
-
Let me start by reminding everyone that I believe the most important relationship in the stock market is how consumer discretionary stocks (XLY) perform relative to consumer staples stocks (XLP).…
-
Do you remember when NVDA stock had a very high StockCharts Technical Rank (SCTR) score for most of 2023 and 2024? If not, that’s OK. You’ll remember when you look…
-
In this video, Dave reveals three common behavioral biases, shows how they can negatively impact your portfolio returns, and describes how to use the StockCharts platform to minimize these biases…
-
“When do I sell?” is easily the most-asked question I’ve received over the years. There are multiple answers to this question based on certain variables. The first key variable is…
-
Today on the S&P 600 (IJR), the 20-day EMA nearly crossed above the 50-day EMA for a “Silver Cross” IT Trend Model BUY Signal. Price is really going nowhere. Bulls…
Older Posts